Analgesic activity of some aroylhydrazone-based molecular hybrids with antiseizure activity: in vivo and in silico evaluations

References

• National Institute for Health and Care Excellence [Internet]. Epilepsies: diagnosis and management. Clinical guideline [CG137]. 2018. Available from: https://www.nice.org.uk/guidance/cg137
   Google Scholar
• Ngugi AK, Kariuki SM, Bottomley C, et al. Incidence of epilepsy: a systematic review and meta-analysis. Neurology. 2011;77:1005–1012.
   PubMed Web of Science ®Google Scholar
• Wilner AN. Comorbidities common even in newly diagnosed epilepsy. Medscape, C. 2016. Available from: https://www.medscape.com/viewarticle/872119
   Google Scholar
• Keezer MR, Sisodiya SM, Sander JW. Comorbidities of epilepsy: current concepts and future perspectives. Lancet Neurol. 2016;15:106–115.
   PubMed Web of Science ®Google Scholar
• Aaberg KM, Bakken IJ, Lossius MI, et al. Comorbidity and childhood epilepsy: a nationwide registry study. Pediatrics. 2016;138:e20160921.
   PubMed Web of Science ®Google Scholar
• Kerr MP. The impact of epilepsy on patients’ lives. Acta Neurol Scand. 2012;194:1–9.
   Google Scholar
• St Germaine-Smith C, Liu M, Quan H, et al. Development of an epilepsy-specific risk adjustment comorbidity index. Epilepsia. 2011;52:2161–2167.
   PubMed Web of Science ®Google Scholar
• Goldberg DS, McGee SJ. Pain as a global public health priority. BMC Public Health. 2011;11:770.
   PubMed Web of Science ®Google Scholar
• Sidhu HS, Sadhotra A. Current status of the new antiepileptic drugs in chronic pain. Front Pharmacol. 2016;7:276.
   PubMed Web of Science ®Google Scholar
• Sörensen J, Graven-Nielsen T, Henriksson KG, et al. Hyperexcitability in fibromyalgia. J Rheumatol. 1998;25:152–155.
   PubMed Web of Science ®Google Scholar
• Ferrari MD, Klever RR, Terwindt GM, et al. Migraine pathophysiology: lessons from mouse models and human genetics. Lancet Neurol. 2015;14:65–80.
   PubMed Web of Science ®Google Scholar
• Ottman R, Lipton RB, Ettinger AB, et al. Comorbidities of epilepsy: results from the Epilepsy Comorbidities and Health (EPIC) survey. Epilepsia. 2011;52:308–315.
   PubMed Web of Science ®Google Scholar
• Cianchetti C, Avanzini G, Dainese F, et al. The complex interrelations between two paroxysmal disorders: a headache and epilepsy. Neurol Sci. 2017;38:941–948.
   PubMed Web of Science ®Google Scholar
• Velioglu SK, Gedikli O, Yıldırım M, et al. Epilepsy may cause increased pain sensitivity: evidence from absence epileptic WAG/Rij rats. Epilepsy Behav. 2017;75:146–150.
   PubMed Web of Science ®Google Scholar
• de Freitas RL, Bolognesi LI, Twardowschy A, et al. Neuroanatomical and neuropharmacological approaches to postictal antinociception-related prosencephalic neurons: the role of muscarinic and nicotinic cholinergic receptors. Brain Behav. 2013;3:286–301.
   PubMed Web of Science ®Google Scholar
• Szűcs A, Horváth A, Rásonyi G, et al. Ictal analgesia in temporal lobe epilepsy – the mechanism of seizure-related burns. Med Hypotheses. 2015;85:173–177.
   PubMed Web of Science ®Google Scholar
• Wiffen PJ, Derry S, Moore RA, et al. Antiepileptic drugs for neuropathic pain and fibromyalgia – an overview of Cochrane reviews. Cochrane Database Syst Rev. 2013;CD010567.
   PubMed Web of Science ®Google Scholar
• Hoffmann J, Akerman S, Goadsby PJ. Efficacy and mechanism of anticonvulsant drugs in migraine. Expert Rev Clin Pharmacol. 2014;7:191–201.
   PubMed Web of Science ®Google Scholar
• Jackson JL, Cogbill E, Santana-Davila R, et al. A comparative effectiveness meta-analysis of drugs for the prophylaxis of migraine headache. PLoS One. 2015;10:e0130733.
   PubMed Web of Science ®Google Scholar
• Ibrar A, Shehzadi SA, Saeed F, et al. Developing hybrid molecule therapeutics for diverse enzyme inhibitory action: the active role of coumarin-based structural leads in drug discovery. Bioorg Med Chem. 2018;26:3731–3762.
   PubMed Web of Science ®Google Scholar
• Gateva P, Tchekalarova J, Angelova VT, et al. Preclinical screening of coumarin and 2 h –chromene substituted hydrazide-hydrazone derivatives, as potential anticonvulsants. Clin Ther. 2017;39:e78–e79.
   Google Scholar
• Chaur MN. Aroylhydrazones as potential systems for information storage: photoisomerization and metal complexation. Rev Colomb Quim. 2012;41:349–358.
   Google Scholar
• Torres FC, Brucker N, Andrade SF, et al. New insights into the chemistry and antioxidant activity of coumarins. Curr Top Med Chem. 2014;14:2600–2623.
   PubMed Web of Science ®Google Scholar
• Hiragi T, Ikegaya Y, Koyama R. Microglia after seizures and in epilepsy. Cells. 2018;7:26.
   PubMed Web of Science ®Google Scholar
• de Vries EE, van den Munckhof B, Braun KP, et al. Inflammatory mediators in human epilepsy: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2016;63:177–190.
   PubMed Web of Science ®Google Scholar
• Ramesh G, MacLean AG, Philipp MT. Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm. 2013;2013:1.
   Google Scholar
• Bannon AW, Malmberg AB. Models of nociception: hot-plate, tail-flick, and formalin tests in rodents. Curr Protoc Neurosci. 2007;41:891–896.
   Google Scholar
• Eddy NB, Leimbach DJ. Synthetic analgesics. II. Dithienylbutenyl- and d dithienylbutylamines. J Pharmacol Exp Ther. 1953;107:385–393.
   PubMed Web of Science ®Google Scholar
• Riedel W, Neeck G. Nociception, pain, and antinociception: current concepts. Z Rheumatol. 2001;60:404–415.
   PubMed Web of Science ®Google Scholar
• Stanley AC, Lacy P. Pathways for cytokine secretion. Physiology (Bethesda). 2010;25:218–229.
   PubMed Web of Science ®Google Scholar
• de Oliveira CM, Sakata RK, Issy AM, et al. Cytokines and pain. Rev Bras Anestesiol. 2011;61:255–259.
   PubMed Web of Science ®Google Scholar
• Okuneva O, Li Z, Körber I, et al. Brain inflammation is accompanied by peripheral inflammation in Cstb -/- mice, a model for progressive myoclonus epilepsy. J Neuroinflammation. 2016;13:298.
   PubMed Web of Science ®Google Scholar
• Strong JA, Xie W, Coyle DE, et al. Microarray analysis of rat sensory ganglia after local inflammation implicates novel cytokines in pain. PLoS One. 2012;7:e40779.
   PubMed Web of Science ®Google Scholar
• Luo J, Wang W, Xi Z, et al. Concentration of soluble adhesion molecules in cerebrospinal fluid and serum of epilepsy patients. J Mol Neurosci. 2014;54:767–773.
   PubMed Web of Science ®Google Scholar
• Luchting B, Hinske LC, Rachinger-Adam B, et al. Soluble intercellular adhesion molecule-1: a potential biomarker for pain intensity in chronic pain patients. Biomarkers Med. 2017;11:265–276.
   PubMed Web of Science ®Google Scholar
• Kodangattil JN, Möddel G, Müller M, et al. The inflammatory chemokine CXCL10 modulates synaptic plasticity and neuronal activity in the hippocampus. Eur J Inflamm. 2012;10:311–328.
   Web of Science ®Google Scholar
• Vazirinejad R, Ahmadi Z, Kazemi Arababadi M, et al. The biological functions, structure and sources of CXCL10 and its outstanding part in the pathophysiology of multiple sclerosis. Neuroimmunomodulation. 2014;21:322–330.
   PubMed Web of Science ®Google Scholar
• Wang Y, Gehringer R, Mousa SA, et al. CXCL10 controls inflammatory pain via opioid peptide-containing macrophages in electroacupuncture. PLoS One. 2014;9:e94696.
   PubMed Web of Science ®Google Scholar
• Walker DG, Lue LF. Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains. Alzheimers Res Ther. 2015;7:56.
   PubMed Web of Science ®Google Scholar
• Martinez FO, Gordon S, Locati M, et al. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol. 2006;177:7303–7311.
   PubMed Web of Science ®Google Scholar
• Cerri C, Caleo M, Bozzi Y. Chemokines as new inflammatory players in the pathogenesis of epilepsy. Epilepsy Res. 2017;136:77–83.
   PubMed Web of Science ®Google Scholar
• Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007;45:27–37.
   PubMedGoogle Scholar
• McNamara CR, Mandel-Brehm J, Bautista DM, et al. TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci USA. 2007;104:13525–13530.
   PubMed Web of Science ®Google Scholar
• Fischer M, Carli G, Raboisson P, et al. The interphase of the formalin test. Pain. 2014;155:511–521.
   PubMed Web of Science ®Google Scholar
• Abbott FV, Franklin KB, Westbrook RF. The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain. 1995;60:91–102.
   PubMed Web of Science ®Google Scholar
• Yin ZY, Li L, Chu SS, et al. Antinociceptive effects of dehydrocorydaline in mouse models of inflammatory pain involve the opioid receptor and inflammatory cytokines. Sci Rep. 2016;6:27129.
   PubMed Web of Science ®Google Scholar
• Naegele JR. Neuroprotective strategies to avert seizure-induced neurodegeneration in epilepsy. Epilepsia. 2007;48:107–117.
   PubMed Web of Science ®Google Scholar
• Akgul C. Mcl-1 is a potential therapeutic target in multiple types of cancer. Cell Mol Life Sci. 2009;66:1326–1336.
   PubMed Web of Science ®Google Scholar
• Thomas LW, Lam C, Edwards SW. Mcl-1: the molecular regulation of protein function. FEBS Lett. 2010;584:2981–2989.
   PubMed Web of Science ®Google Scholar
• Sima X, Xu J, Li J, et al. Expression of β-amyloid precursor protein in refractory epilepsy. Mol Med Rep. 2014;9:1242–1248.
   PubMed Web of Science ®Google Scholar
• Löscher W, Lehmann H, Teschendorf HJ, et al. Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy. J Pharmacol Exp Ther. 1999;288:984–992.
   PubMed Web of Science ®Google Scholar
• Svob Strac D, Pivac N, Smolders IJ, et al. Monoaminergic mechanisms in epilepsy may offer innovative therapeutic opportunity for monoaminergic multi-target drugs. Front Neurosci. 2016;10:492.
   PubMed Web of Science ®Google Scholar
• Villarinho JG, Oliveira SM, Silva CR, et al. Involvement of monoamine oxidase B on models of postoperative and neuropathic pain in mice. Eur J Pharmacol. 2012;690:107–114.
   PubMed Web of Science ®Google Scholar
• Barrot M. Tests and models of nociception and pain in rodents. Neuroscience. 2012;211:39–50.
   PubMed Web of Science ®Google Scholar
• Yudkoff M, Daikhin Y, Nissim I, et al. Ketogenic diet, brain glutamate metabolism and seizure control. Prostaglandins Leukot Essent Fatty Acids. 2004;70:277–285.
   PubMed Web of Science ®Google Scholar
• Guzmán M, Blázquez C. Is there an astrocyte-neuron ketone body shuttle? Trends Endocrinol Metab. 2001;12:169–173.
   PubMed Web of Science ®Google Scholar
• Wang J, Lin ZJ, Liu L, et al. Epilepsy-associated genes. Seizure. 2017;44:11–20.
   PubMed Web of Science ®Google Scholar
• Naviaux RK. Metabolic features of the cell danger response. Mitochondrion. 2014;16:7–17.
   PubMed Web of Science ®Google Scholar
• Kim DY, Abdelwahab MG, Lee SH, et al. Ketones prevent oxidative impairment of hippocampal synaptic integrity through KATP channels. PLoS One. 2015;10:e0119316.
   PubMed Web of Science ®Google Scholar
• Shimazu T, Hirschey MD, Newman J, et al. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 2013;339:211–214.
   PubMed Web of Science ®Google Scholar
• Marchi N, Granata T, Janigro D. Inflammatory pathways of seizure disorders. Trends Neurosci. 2014;37:55–65.
   PubMed Web of Science ®Google Scholar
• Grabacka M, Pierzchalska M, Dean M, et al. Regulation of ketone body metabolism and the role of PPARα. IJMS. 2016;17:2093.
   Google Scholar
• Rojas-Morales P, Tapia E, Pedraza-Chaverri J. β-Hydroxybutyrate: a signaling metabolite in starvation response? Cell Signal. 2016;28:917–923.
   PubMed Web of Science ®Google Scholar